TL;DR
Finding a new drug has usually meant years spent screening candidate molecules and hoping a few stick to the right target. Chai Discovery, an AI company in San Francisco, says the drug giant Roche will now use its models "across its therapeutic areas" to design protein-based drugs, the family that includes antibodies, on a computer from scratch, including against targets that older methods struggled to reach. The details, the numbers and our odds on what comes next are below the line. Subscribe to read them.
Below the line, for paid subscribers: The full story: where it stands, how we got here and what's dated next; our labeled speculation on what it adds up to; and every source.



